Abzena hires Matthew Stober to lead the company through the next phase of global growth

San Diego, CA, 10th January 2023 – Abzena, the leading end-to-end integrated CDMO for Antibody Drug Conjugates (ADCs) and complex biologic molecules, announced today that Matthew Stober has joined as their new Chief Executive Officer.
More info >>